Chandelier
Senior Member (Voting Rights)
Neurological manifestations in pediatric COVID-19: a comparative single-center study
Abstract
Objective
To compare clinical characteristics, investigations, management, and outcomes of hospitalized children with SARS-CoV-2 infection with and without neurological involvement, and to determine whether neurological disease reflects systemic severity or a distinct clinical pattern.
Methods
We conducted a retrospective observational study of children aged 1 month–16 years with laboratory-confirmed SARS-CoV-2 infection admitted to a tertiary pediatric center between June 2022 and June 2023. Patients were divided into those with neurological manifestations (ND group, n = 24) and those without neurological involvement (non-ND group, n = 23). Demographic features, clinical presentation, laboratory and neuroimaging findings, treatment, and outcomes were compared.
Results
Children with neurological involvement were significantly older (median 5.75 vs. 3.00 years, p = 0.022) and less likely to present with fever or systemic inflammatory features. They demonstrated lower inflammatory markers and significantly less cardiac involvement, including dilated cardiomyopathy.
Common neurological presentations included encephalopathy (50%), headache (45.8%), and seizures (20.8%). 37% met MIS-C criteria. Neuroimaging revealed lacunar infarctions, demyelinating white matter lesions, longitudinally extensive transverse myelitis, and cauda equina nerve root enhancement.
Despite similar mortality rates, children with neurological involvement had a significantly higher rate of incomplete recovery, with more than a quarter experiencing persistent neurological sequelae (29.2% vs. 4.3%, p = 0.048).
Conclusion
Neurological manifestations of pediatric COVID-19 represent a clinically distinct pattern characterized by limited systemic inflammation but an increased risk of persistent neurological sequelae.
Early neurological evaluation, appropriate neuroimaging, and structured long-term follow-up are warranted even in the absence of severe systemic illness.
Web | DOI | PDF | Acta Neurologica Belgica 2026 | Open Access
Ibrahim, Hanan; Mansour, Mervat; Ahmed, Ahmed R.; Rushdy, Marwa; ElGammal, Mona Mostafa; Zaitoun, Raghda
Abstract
Objective
To compare clinical characteristics, investigations, management, and outcomes of hospitalized children with SARS-CoV-2 infection with and without neurological involvement, and to determine whether neurological disease reflects systemic severity or a distinct clinical pattern.
Methods
We conducted a retrospective observational study of children aged 1 month–16 years with laboratory-confirmed SARS-CoV-2 infection admitted to a tertiary pediatric center between June 2022 and June 2023. Patients were divided into those with neurological manifestations (ND group, n = 24) and those without neurological involvement (non-ND group, n = 23). Demographic features, clinical presentation, laboratory and neuroimaging findings, treatment, and outcomes were compared.
Results
Children with neurological involvement were significantly older (median 5.75 vs. 3.00 years, p = 0.022) and less likely to present with fever or systemic inflammatory features. They demonstrated lower inflammatory markers and significantly less cardiac involvement, including dilated cardiomyopathy.
Common neurological presentations included encephalopathy (50%), headache (45.8%), and seizures (20.8%). 37% met MIS-C criteria. Neuroimaging revealed lacunar infarctions, demyelinating white matter lesions, longitudinally extensive transverse myelitis, and cauda equina nerve root enhancement.
Despite similar mortality rates, children with neurological involvement had a significantly higher rate of incomplete recovery, with more than a quarter experiencing persistent neurological sequelae (29.2% vs. 4.3%, p = 0.048).
Conclusion
Neurological manifestations of pediatric COVID-19 represent a clinically distinct pattern characterized by limited systemic inflammation but an increased risk of persistent neurological sequelae.
Early neurological evaluation, appropriate neuroimaging, and structured long-term follow-up are warranted even in the absence of severe systemic illness.
Web | DOI | PDF | Acta Neurologica Belgica 2026 | Open Access